Bogart Wealth LLC’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $49.8K | Hold |
262
| – | – | ﹤0.01% | 540 |
|
|
2026
Q1 | $44.2K | Hold |
262
| – | – | ﹤0.01% | 523 |
|
|
2025
Q4 | $44.1K | Hold |
262
| – | – | ﹤0.01% | 503 |
|
|
2025
Q3 | $37.8K | Buy |
262
+1
| +0.4% | +$136 | ﹤0.01% | 517 |
|
|
2025
Q2 | $33.1K | Sell |
261
-173
| -40% | -$21.2K | ﹤0.01% | 529 |
|
|
2025
Q1 | $55.6K | Hold |
434
| – | – | ﹤0.01% | 401 |
|
|
2024
Q4 | $57.4K | Buy |
434
+173
| +66% | +$24.3K | ﹤0.01% | 385 |
|
|
2024
Q3 | $38.1K | Sell |
261
-55
| -17% | -$7.96K | ﹤0.01% | 460 |
|
|
2024
Q2 | $43.4K | Sell |
316
-215
| -40% | -$28.7K | ﹤0.01% | 430 |
|
|
2024
Q1 | $72.9K | Buy |
531
+55
| +12% | +$7.51K | ﹤0.01% | 323 |
|
|
2023
Q4 | $64.7K | Sell |
476
-96
| -17% | -$11.7K | ﹤0.01% | 329 |
|
|
2023
Q3 | $70K | Sell |
572
-14,209
| -96% | -$1.81M | ﹤0.01% | 291 |
|
|
2023
Q2 | $1.88M | Buy |
14,781
+988
| +7% | +$128K | 0.12% | 108 |
|
|
2023
Q1 | $1.78M | Buy |
13,793
+504
| +4% | +$66K | 0.12% | 105 |
|
|
2022
Q4 | $1.74M | Buy |
13,289
+6,993
| +111% | +$904K | 0.12% | 108 |
|
|
2022
Q3 | $736K | Buy |
6,296
+6,095
| +3,032% | +$757K | 0.06% | 119 |
|
|
2022
Q2 | $24K | Hold |
201
| – | – | ﹤0.01% | 390 |
|
|
2022
Q1 | $26K | Sell |
201
-114
| -36% | -$14.8K | ﹤0.01% | 350 |
|
|
2021
Q4 | $48K | Buy |
315
+75
| +31% | +$11.6K | ﹤0.01% | 265 |
|
|
2021
Q3 | $39K | Buy |
240
+39
| +19% | +$6.56K | ﹤0.01% | 273 |
|
|
2021
Q2 | $33K | Hold |
201
| – | – | ﹤0.01% | 282 |
|
|
2021
Q1 | $30K | Hold |
201
| – | – | ﹤0.01% | 276 |
|
|
2020
Q4 | $30K | Hold |
201
| – | – | 0.01% | 233 |
|
|
2020
Q3 | $27K | Hold |
201
| – | – | 0.01% | 235 |
|
|
2020
Q2 | $27K | Hold |
201
| – | – | 0.01% | 218 |
|
|
2020
Q1 | $22K | Hold |
201
| – | – | 0.01% | 213 |
|
|
2019
Q4 | $24K | Hold |
201
| – | – | 0.01% | 223 |
|
|
2019
Q3 | $20K | Sell |
201
-241
| -55% | -$25.2K | 0.01% | 215 |
|
|
2019
Q2 | $48K | Hold |
442
| – | – | 0.03% | 149 |
|
|
2019
Q1 | $49K | Hold |
442
| – | – | 0.02% | 141 |
|
|
2018
Q4 | $42K | Sell |
442
-33
| -7% | -$3.5K | 0.02% | 154 |
|
|
2018
Q3 | $58K | Hold |
475
| – | – | 0.03% | 134 |
|
|
2018
Q2 | $52K | Sell |
475
-9,431
| -95% | -$1.01M | 0.03% | 141 |
|
|
2018
Q1 | $1.03M | Buy |
9,906
+878
| +10% | +$97.3K | 0.6% | 35 |
|
|
2017
Q4 | $964K | Sell |
9,028
-728
| -7% | -$77.8K | 0.62% | 36 |
|
|
2017
Q3 | $1.1M | Buy |
9,756
+90
| +0.9% | +$9.62K | 0.82% | 30 |
|
|
2017
Q2 | $999K | Sell |
9,666
-555
| -5% | -$54.7K | 0.64% | 32 |
|
|
2017
Q1 | $999K | Sell |
10,221
-495
| -5% | -$47.4K | 0.66% | 29 |
|
|
2016
Q4 | $948K | Buy |
+10,716
| New | +$975K | 0.64% | 30 |
|
Other funds holding IBB
CB
Bogart Wealth LLC's IBB Position: Q2 2026 in Review
Bogart Wealth LLC held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 262 shares worth $49.8K. The position accounts for ﹤0.01% of the portfolio, ranked #540.
Bogart Wealth LLC first reported a position in IBB in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.88M in Q2 2023. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Bogart Wealth LLC held 262 shares of iShares Biotechnology ETF worth $49.8K as of Q2 2026.
- Bogart Wealth LLC left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #540 holding.
- Bogart Wealth LLC first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 39 quarters since.
- Bogart Wealth LLC's iShares Biotechnology ETF position peaked at $1.88M in Q2 2023.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.